GlaxoSmithKline PLC (GSK)

43.90
0.51 1.15
NYSE : Health Care
Prev Close 44.41
Open 44.44
Day Low/High 43.82 / 44.54
52 Wk Low/High 37.24 / 45.58
Volume 2.60M
Avg Volume 3.44M
Exchange NYSE
Shares Outstanding 2.44B
Market Cap 107.49B
EPS 5.20
P/E Ratio 25.36
Div & Yield 2.00 (4.50%)

Latest News

9 Stocks for the Bank of England's Corporate-Bond Purchases

9 Stocks for the Bank of England's Corporate-Bond Purchases

Which stocks will be most favored by the corporate-bond purchases?

GSK Unveils Campaign To Help Prevent Meningitis

GSK Unveils Campaign To Help Prevent Meningitis

Parents, young adults urged to educate themselves about meningitis B, responsible for one-third of U.S. cases[1]

4 Stocks to Buy in This Vulnerable Market

4 Stocks to Buy in This Vulnerable Market

This market is like a leaky helium balloon; watch out for sudden downdrafts.

We've Just Found the 'Apple' of Biotechnology

We've Just Found the 'Apple' of Biotechnology

Two companies, one a tech giant and the other a Big Pharma stalwart, have formed a joint venture that's bringing disruptive technology to new drug development.

Here's Why GlaxoSmithKline's Stock Is Ready to Scale New Heights

Here's Why GlaxoSmithKline's Stock Is Ready to Scale New Heights

This big pharma blue chip is on a growth trajectory that often eludes companies of its massive size.

Alphabet and Glaxo Team Up to Jumpstart Your Profits

Alphabet and Glaxo Team Up to Jumpstart Your Profits

The Google parent and Big Pharma major have announced a joint venture into the developing world of bioelectronics treatments.

Portfolio Roundup: Humira Helps Buoy AbbVie Shares

Portfolio Roundup: Humira Helps Buoy AbbVie Shares

The drug maker continued to rally Monday.

GlaxoSmithKline (GSK) Chairman Slaoui to CNBC: Bioelectronics a 'Whole new Industry'

GlaxoSmithKline (GSK) Chairman Slaoui to CNBC: Bioelectronics a 'Whole new Industry'

GlaxoSmithKline's (GSK) Dr. Slaoui believes the company's partnership with Alphabet (GOOGL) will create new nano devices to treat chronic diseases.

GlaxoSmithKline Inks Medical 'Bioelectronics' Partnership With Alphabet

GlaxoSmithKline Inks Medical 'Bioelectronics' Partnership With Alphabet

The pharmaceutical giant is teaming up with Google's parent with as much as $715 million in joint investments.

Morning Movers: GSK, GOOGL, SCTY, TSLA

Morning Movers: GSK, GOOGL, SCTY, TSLA

GlaxoSmithKline and Google's parent Alphabet announced their joint plan to pioneer a new form of electronic medical treatment.

5 Things You Must Know Before the Market Opens Monday

5 Things You Must Know Before the Market Opens Monday

Uber reaches an agreement for its China operations to be acquired by local rival Didi Chuxing; Fed's Dudley says don't rule out rate hike this year; U.S. stock futures rise.

Glaxo Teams Up with Alphabet on Bioelectronic Med Deal

Glaxo Teams Up with Alphabet on Bioelectronic Med Deal

The companies will invest $715 million over seven years to develop miniature implantable devices to help chronic diseases.

AstraZeneca Earnings, Sales Edge Above Forecasts

AstraZeneca Earnings, Sales Edge Above Forecasts

CEO Soriot says the company's pipeline is progressing well, and predicts a boost to full-year earnings from a decline in the pound.

3 Stocks Boosting The Health Care Sector Higher

3 Stocks Boosting The Health Care Sector Higher

TheStreet highlights 3 stocks pushing the health care sector higher today.

European Markets Up as Car Makers Surge

European Markets Up as Car Makers Surge

Volkswagen gains 2.36% ahead of earnings release tomorrow.

GlaxoSmithKline Rallies on Strong Quarterly Results

GlaxoSmithKline Rallies on Strong Quarterly Results

The U.K.'s leading drugs group lifts its forecast for the full year and confirms dividend payout plans.

Global Week Ahead: Report Card Time for European Banks, BOJ Monetary Policy Meeting

Global Week Ahead: Report Card Time for European Banks, BOJ Monetary Policy Meeting

Expect a barrage of key indicators and earnings from companies including Deutsche Bank, LVMH, Diageo and AB InBev.

European Stock Markets Mixed After Signs of Brexit Damage

European Stock Markets Mixed After Signs of Brexit Damage

Purchasing managers' surveys point toward a slowdown in U.K services and manufacturing

3 Hold-Rated Dividend Stocks: DRH, GSK, DBD

3 Hold-Rated Dividend Stocks: DRH, GSK, DBD

These 3 dividend stocks are rated a Hold by TheStreet

Celgene, Jounce Therapeutics in Early Cancer Immunotherapy Development Pact

Celgene, Jounce Therapeutics in Early Cancer Immunotherapy Development Pact

Celgene continues to sprinkle cash around the biotech sector, tying up with smaller companies for first-dibs access to potentially valuable drugs and technologies.

Novartis Second-Quarter Earnings, Revenue Fall Less Than Forecast

Novartis Second-Quarter Earnings, Revenue Fall Less Than Forecast

The pharmaceuticals company, led by CEO Joe Jiminez, had its first full quarter of generic competition for its Gleevec cancer drug.

SoftBank Spurs Post-Brexit U.K. M&A Hopes With ARM Bid

SoftBank Spurs Post-Brexit U.K. M&A Hopes With ARM Bid

As a bombed-out pound leaves British assets at a discount, who will be next in the post-Brexit M&A binge?

Grab a Bit of Britain With FTSE 100 ETF

Grab a Bit of Britain With FTSE 100 ETF

The U.K. isn't going anywhere Brexit vote notwithstanding, and here's a way to get on the most business-friendly state across the pond.

European Markets Mixed After Bank of England Keeps Rate Steady

European Markets Mixed After Bank of England Keeps Rate Steady

Bank of England defies market expectations and keeps rate at 0.5%; expects easing in August.

Glaxo Gains Jefferies Upgrade on Stronger HIV Drugs Performance, Currency Benefits

Glaxo Gains Jefferies Upgrade on Stronger HIV Drugs Performance, Currency Benefits

Shares in the U.K.'s leading pharmaceuticals company have risen about 20% since the June 23 Brexit vote.

European Markets Pare Gains After Bank of England Keeps Rate Steady

European Markets Pare Gains After Bank of England Keeps Rate Steady

Bank of England defies market expectations and keeps rate at 0.5%

European Stocks Rise Ahead of Expected Bank of England Rate Cut

European Stocks Rise Ahead of Expected Bank of England Rate Cut

UniCredit rises after the bank's chairman says asset sales won't address ECB capital demands, while BASF gains in Frankfurt on talk of the transfer of an agricultural unit to Monsanto.